10.01.2011 • NewsU.S. Supreme CourtIMS Health

Vermont Drug Mining Law Decision Expected from U.S. Supreme Court

The U.S. Supreme Court said on Friday that it would decide whether a state law restricting commercial access to information about prescription drug records violated constitutional free-speech rights.

The justices agreed to review a data mining law adopted in 2007 in Vermont that prevented the sale, transmission or use of prescriber-identifiable information for marketing a prescription drug unless the prescribing doctor consented.

The law was challenged by three companies - IMS Health, Verispan and Source Healthcare Analytics, a unit of Dutch publisher Wolters Kluwer-that collect and sell such data and by a trade group for pharmaceutical manufacturers.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.